T TIANDB Active member Joined Jul 5, 2018 Messages 38 Reason PALS Diagnosis 06/2018 Country Uni State Derbyshire City Matlock Aug 6, 2018 #1 A new trial Phase 1/2a, open - Label, Dose escalating study. Based on anti Inflammation, with Intravenous administration of IPL 344 ? Apparently used by one compassionate use patient and showed to halt progression for two years ? Last edited by a moderator: Aug 6, 2018
A new trial Phase 1/2a, open - Label, Dose escalating study. Based on anti Inflammation, with Intravenous administration of IPL 344 ? Apparently used by one compassionate use patient and showed to halt progression for two years ?
